XML 93 R83.htm IDEA: XBRL DOCUMENT v3.23.3
Loss Per Common Share - Computation of Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]        
Income (loss) from continuing operations $ (25,324) $ 2,123 $ (79,629) $ (7,352)
Loss from discontinued operations, net of tax [1] 0 0 0 (463)
Income (loss) before preferred dividends and accretion of Series A Preferred Stock (25,324) 2,123 (79,629) (7,815)
Dividends and accretion of Series A Preferred Stock (7,872) 0 (21,236) 0
Net income (loss) attributable to common shareholders of Evolent Health, Inc. - Basic (33,196) 2,123 (100,865) (7,815)
Net income (loss) attributable to common shareholders of Evolent Health, Inc., Inc. - Diluted $ (33,196) $ 2,123 $ (100,865) $ (7,815)
Weighted-average common shares outstanding - basic (in shares) 112,282 95,286 110,464 91,643
Incremental diluted shares from stock options (in shares) 0 1,915 0 0
Incremental diluted shares from restricted stock units ("RSUs"), performance-based RSUs (“PSUs”) and leveraged stock units ("LSUs") (in shares) 0 2,107 0 0
Weighted-average common shares outstanding - diluted (in shares) 112,282 99,308 110,464 91,643
Basic:        
Continuing operations (in dollars per share) $ (0.30) $ 0.02 $ (0.91) $ (0.08)
Discontinued operations (in dollars per share) 0 0 0 (0.01)
Basic income (loss) per share attributable to common shareholders of Evolent Health, Inc, (in dollars per share) (0.30) 0.02 (0.91) (0.09)
Diluted:        
Continuing operations (in dollars per share) (0.30) 0.02 (0.91) (0.08)
Discontinued operations (in dollars per share) 0 0 0 (0.01)
Diluted income (loss) per share attributable to common shareholders of Evolent Health, Inc, (in dollars per share) $ (0.30) $ 0.02 $ (0.91) $ (0.09)
[1] Includes $(0.5) million loss on disposal for of discontinued operations for the nine months ended September 30, 2022.